This inventor holds 6 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Olympus Corporation. Active years: 2012-2021.
Location History:
- Tokyo, JP (2012 - 2013)
- Higashimurayama, JP (2017 - 2021)
Company Filing History:
Years Active: 2012-2021
Title: The Innovations of Tomoharu Ogihara
Introduction
Tomoharu Ogihara is a notable inventor based in Higashimurayama, Japan. He has made significant contributions to the field of imaging devices and endoscopes, holding a total of 6 patents. His work has advanced the technology used in medical imaging and diagnostics.
Latest Patents
Ogihara's latest patents include an imaging device and an endoscope apparatus. The imaging device features a pixel unit arranged in a two-dimensional matrix, which generates an imaging signal based on the amount of light received. It also includes an A/D converter for converting the imaging signal into a digital format, a switch for connecting the A/D converter, and a controller to manage the timing of these connections. The endoscope apparatus consists of image sensors, a power supply unit, a failure detection unit, and a controller. This design allows for independent power supply to the image sensors and includes a mechanism for detecting and responding to sensor failures.
Career Highlights
Throughout his career, Ogihara has worked with prominent companies such as Olympus Corporation and Olympos Corporation. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects in the field of medical technology.
Collaborations
Ogihara has collaborated with notable colleagues, including Fumiyuki Okawa and Keisuke Ogawa. These partnerships have fostered a creative environment that has led to the development of groundbreaking technologies.
Conclusion
Tomoharu Ogihara's contributions to imaging devices and endoscopes highlight his role as a significant inventor in the medical technology sector. His innovative patents and collaborations continue to influence advancements in this critical field.
